ProPhase Labs Faces Unsealed False Claims Act Lawsuit
ProPhase Labs Inc. faces an unsealed False Claims Act lawsuit filed in 2023, revealed by the U.S. District Court for the Eastern District of New York. The company denies wrongdoing, asserting compliance with regulatory standards, and plans to defend itself vigorously. It does not expect the litigation to affect its operations. Previous disputes with the plaintiff were resolved in 2024. The news was generated by Public Technologies using AI and is based on ProPhase Labs' EDGAR filing.
ProPhase Labs Inc. has disclosed that a previously sealed civil action under the False Claims Act, originally filed in 2023, has been unsealed by the United States District Court for the Eastern District of New York. The company stated it had no prior knowledge of the lawsuit until receiving notice of the unsealing on November 21, 2025. ProPhase Labs denies any wrongdoing and asserts that its laboratory and diagnostic operations adhere to strict regulatory and compliance standards. The company does not expect the litigation to impact its ongoing operations or services and intends to vigorously defend itself in the matter. All prior private disputes with the plaintiff were resolved and dismissed in 2024, and are separate from the current qui tam action. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-024988), on November 25, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
